Impact of daratumumab-based induction on stem cell collection parameters in Swedish myeloma patients

Haematologica. 2023 Feb 1;108(2):610-614. doi: 10.3324/haematol.2022.281610.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols
  • Humans
  • Multiple Myeloma* / drug therapy
  • Stem Cells
  • Sweden

Substances

  • daratumumab
  • Antibodies, Monoclonal

Grants and funding

Funding: This work was supported by grants from ALF and Swedish Cancer foundation.